CliffBio
small molecule

ESTRADERM

ESTRADIOL

Loss of exclusivity—loss of exclusivity
CompanyNovartis →See this company's full patent-cliff portfolio

Drug detail

Brand nameESTRADERM
Active ingredientESTRADIOL
Strength0.05MG/24HR
Dosage formSYSTEM
RouteTRANSDERMAL
ModalitySmall molecule
FDA approvalSeptember 1986
Marketing statusDISCN

More from Novartis

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.